MaxDiscovery™ Aspartate Transaminase (AST) Enzymatic Assay Kit

Products > Life Science > Preclinical Chemistry > Toxicity

Catalog#

Product Name

Quantity

US List Price

3460-02

MaxDiscovery™ Aspartate Transaminase (AST) Enzymatic Assay Kit

1 x 96 wells

$276

Benefits

· High sensitivity with low detection limit (20 U/L)
· Rapid – results in 5 minutes
· Robust kinetic assay
· Does not require expensive instrumentation
· Highly reproducible results
· Only requires 10 uL of serum
· Measure absorbance in UV spectrum (340 nm)

Description

The MaxDiscovery™ Aspartate Transaminase (AST) Enzymatic Assay Kit is a plate-based colorimetric enzymatic assay for the determination of the aspartate transaminase enzyme in 10 µL of serum from rodents or other mammals. Aspartate transaminase (AST) also known as aspartate aminotransferase or (sGOT) is a metabolic enzyme expressed primarily in the liver. Elevation of AST levels is an indication of liver damage and has been associated with liver injury. AST levels are monitored routinely in patients with liver diseases. AST is also a very useful tool for preclinical investigation of experimental drug formulations and AST levels are commonly used to monitor and attenuate the hepatotoxic effects of experimental drugs in rodents.

Key Features

The MaxDiscovery™ Aspartate Transaminase (AST) Enzymatic Assay Kit has the capacity for 96 determinations or testing of 42 samples in duplicate (using 12 wells for standards). The kit also contains enough material to construct four standard curves. Store the kit at 4°C. The shelf life of the kit is 6 months, after receipt, when the kit is properly stored.

Selected References:

Fang X, Wang R, Ma J, Ding Y, Shang W, et al. (2012) Ameliorated ConA-Induced Hepatitis in the Absence of PKC-theta. PLoS ONE 7(2): e31174. doi:10.1371/journal.pone.0031174

Kühnel, F. et al. (29 December 2009) Targeting of p53-Transcriptional Dysfunction by Conditionally Replicating Adenovirus Is Not Limited by p53-Homologues. Mol. Ther. http://www.nature.com/mt/journal/vaop/ncurrent/full/mt2009298a.html

Patel R, Baker SS, Liu W, Desai S, Alkhouri R, et al. (2012) Effect of Dietary Advanced Glycation End Products on Mouse Liver. PLoS ONE 7(4): e35143. doi:10.1371/journal.pone.0035143

Wu, S.Y. et al. (12 August 2010) Systemic delivery of E6/7 siRNA using novel lipidic particles and its application with cisplatin in cervical cancer mouse models. Gene Therapy. http://www.nature.com/gt/journal/vaop/ncurrent/full/gt2010113a.html

Rink, C. et al. (2011) Oxygen-Inducible Glutamate Oxaloaceate Transaminase as Protective Switch Transforming Neurotoxic Glutamate to Metabolic Fuel During Acute Ischemic Stroke. Antioxid Redox Sign., 14: 1777 – 1785.

Venkatesh, M., et al. (July, 2011) In Vivo and In Vitro Characterization of a First-in-Class Novel Azole Analog That Targets Pregnane X Receptor Activation. Molecular Pharmacology 80(1): 124-135.


	Sitemap	Terms of Use	Privacy Policy	Careers
Bioo Scientific Corp., 3913 Todd Lane Suite 312 Austin, TX 78744, USA - Phone: 888-208-2246 Copyright © 2013